Overview
Hamartoma PBMC
Hamartoma PBMC is collected from IRB-consented donors diagnosed with clinically confirmed Hamartoma. These peripheral blood mononuclear cell (PBMC) samples are ideal for characterizing peripheral immune cell populations and their role in benign tissue overgrowth. These PBMC samples support analysis of immune cell signaling and gene expression in non-malignant tumor contexts, enabling mechanistic studies of developmental anomalies and tissue dysregulation.
Product Features
- Cryopreserved, clinically verified hamartoma human PBMC samples
- Customizable formats and anticoagulant options available
- Cryopreserved to ensure stability and long-term storage
- Research Use Only (RUO)
Donor Metadata
- Clinically confirmed Hamartoma diagnosis
- Donor demographics: age, sex assigned at birth, ethnicity
- Medical and treatment history available when applicable
Applications
- Characterizing peripheral immune cell populations and their role in benign tissue overgrowth
- Biomarker discovery and validation
- Transcriptomic, proteomic, or functional studies
- Custom assay development and disease modeling
Compliance and Quality
- IRB-approved collection and electronic informed consent
- HIPAA-compliant donor data handling
Ordering and Customization
Hamartoma PBMC is available in standard and custom volumes. Contact [email protected] for international requests or documentation needs.
Protocols and Documentation
Publications
Data and Testing
Data and Testing with Every Sample
- Donor demographics
- Donor-reported allergies
- Donor-reported infectious disease history
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.